https://alzheimereurope.newsweaver.com/Newsletter/ en-us 31 Aug 2020 10:00:04 CEST 31 Aug 2020 10:00:04 CEST https://alzheimereurope.newsweaver.com/Newsletter/rss.xml Newsweaver info@alzheimer-europe.org () support@newsweaver.ie (Newsweaver) 60 true https://alzheimereurope.newsweaver.com/Newsletter/1hb6d05tway?lang=en?rss=true Alzheimer Europe’s July-August 2020 [ https://alzheimereurope.newsweaver.com/Newsletter/qzif1ltk1s2/external ] newsletter [ https://alzheimereurope.newsweaver.com/Newsletter/qzif1ltk1s2/external ] [ https://alzheimereurope.newsweaver.com/Newsletter/qzif1ltk1s2/external ] brings you the latest news on developments in the dementia field, across Europe and beyond. Summaries of a few of our top stories appear below. Our monthly newsletter reaches around 11,000 people and we are always happy to receive feedback, or suggestions regarding news items to share in future issues. Click here to download full newsletter [ https://alzheimereurope.newsweaver.com/Newsletter/qzif1ltk1s2/external ] [ https://alzheimereurope.newsweaver.com/Newsletter/qzif1ltk1s2/external ] 28 Aug 2020 12:00:00 CEST 568b2055c8be0290753edc1ad15e8a40 Feature Article <p style="text-align: justify;"><img align="left" src="http://alzheimereurope.newsweaver.com/v2files/shard1/56305/0e/2ca7306d7201d87bf8267c.jpg" style="margin: 5px;" width="101" height="150" hspace="5" vspace="5" alt="" />Alzheimer Europe’s <a href="https://alzheimereurope.newsweaver.com/Newsletter/qzif1ltk1s2/external" target="_blank" rel="noopener"><strong>July-August 2020</strong> <strong>newsletter</strong></a> brings you the latest news on developments in the dementia field, across Europe and beyond.</p> <p style="text-align: justify;">Summaries of a few of our top stories appear below.</p> <p style="text-align: justify;">Our monthly newsletter reaches around 11,000 people and we are always happy to receive feedback, or suggestions regarding news items to share in future issues.</p> <p style="text-align: justify;"> </p> <p style="text-align: justify;"><a href="https://alzheimereurope.newsweaver.com/Newsletter/qzif1ltk1s2/external" target="_blank" rel="noopener"><strong>Click here to download full newsletter</strong></a></p> https://alzheimereurope.newsweaver.com/Newsletter/fzq0cei3shw?lang=en?rss=true On 8 July, the biotechnology company Biogen completed the submission of a biologics license application to the US Food and Drug Administration (FDA) for aducanumab as a treatment for Alzheimer’s disease (AD). Biogen requested a priority, six-month review, which has since been granted by the FDA, meaning a response will be given by 7 March 2021. 29 Aug 2020 12:00:00 CEST d73eb1ca230f00e99e06fc09a13a85b3 Other Articles <p style="text-align: justify;"><img align="left" src="http://alzheimereurope.newsweaver.com/v2files/shard1/56305/eb/ce95a329ac44c0a143986b.jpeg" style="margin: 5px;" width="150" height="79" hspace="5" vspace="5" alt="" />On 8 July, the biotechnology company Biogen completed the submission of a biologics license application to the US Food and Drug Administration (FDA) for aducanumab as a treatment for Alzheimer’s disease (AD). Biogen requested a priority, six-month review, which has since been granted by the FDA, meaning a response will be given by 7 March 2021.</p> https://www.alzheimer-europe.org/News/Science-watch/Wednesday-08-July-2020-Biogen-files-for-FDA-license-for-aducanumab https://alzheimereurope.newsweaver.com/Newsletter/1hproclj72u?lang=en?rss=true On 28 July 2020, following engagement with its national members, research funders and industry partners, Alzheimer Europe issued a position statement highlighting the pressure on dementia research as a result of COVID-19. To address these issues, the position statement sets out a number of recommendations aimed at research funders and research institutions. 29 Aug 2020 12:00:00 CEST 4877b60a36e326e3af8b747db06d323e Other Articles <p style="text-align: justify;"><img align="left" src="http://alzheimereurope.newsweaver.com/v2files/shard1/56305/24/36cb7267192660625abca3.jpg" style="margin: 5px;" width="150" height="100" hspace="5" vspace="5" alt="" />On 28 July 2020, following engagement with its national members, research funders and industry partners, Alzheimer Europe issued a position statement highlighting the pressure on dementia research as a result of COVID-19. To address these issues, the position statement sets out a number of recommendations aimed at research funders and research institutions.</p> https://www.alzheimer-europe.org/News/Alzheimer-Europe/Tuesday-28-July-2020-Alzheimer-Europe-calls-for-urgent-action-to-address-the-impact-of-COVID-19-on-dementia-research https://alzheimereurope.newsweaver.com/Newsletter/111ljhrejey?lang=en?rss=true The 2020 Lancet Commission on dementia prevention, intervention and care identifies 12 modifiable risk factors that may account for 40% of dementia cases. Theoretically, modification of these risk factors could prevent or delay the development of dementia. 29 Aug 2020 12:00:00 CEST e04767c2132c2e98db13a3d8827fb45c Other Articles <p style="text-align: justify;"><img align="left" src="http://alzheimereurope.newsweaver.com/v2files/shard1/56305/75/36eb8d0f5255a98b3cb095.png" style="margin: 5px;" width="150" height="71" hspace="5" vspace="5" alt="" />The 2020 Lancet Commission on dementia prevention, intervention and care identifies 12 modifiable risk factors that may account for 40% of dementia cases. Theoretically, modification of these risk factors could prevent or delay the development of dementia.</p> https://www.alzheimer-europe.org/News/Science-watch/Thursday-30-July-2020-Lancet-Commission-on-dementia-prevention-intervention-and-care-identifies-12-modifiable-risk-factors-accounting-for-40-of-dementias https://alzheimereurope.newsweaver.com/Newsletter/cdl62ffk3ss?lang=en?rss=true Registration is now open for the 30th Alzheimer Europe Conference (#30AEC), taking place online from 20 to 22 October. Take advantage of the early bird registration fees until 15 September 2020, with a reduced registration fee of EUR 75 instead of EUR 125. 29 Aug 2020 12:00:00 CEST ec6865b278a980342df80f4f0010ac8e Other Articles <p style="text-align: justify;"><img align="left" src="http://alzheimereurope.newsweaver.com/v2files/shard1/56305/dc/2c87528a58489c9eef617f.jpg" style="margin: 5px;" width="150" height="100" hspace="5" vspace="5" alt="" />Registration is now open for the 30<sup>th</sup> Alzheimer Europe Conference (#30AEC), taking place online from 20 to 22 October. Take advantage of the early bird registration fees until 15 September 2020, with a reduced registration fee of EUR 75 instead of EUR 125.</p> https://www.alzheimer-europe.org/News/Alzheimer-Europe/Thursday-06-August-2020-Register-now-for-the-30th-Alzheimer-Europe-Online-Conference https://alzheimereurope.newsweaver.com/Newsletter/1pnltaw8aqt?lang=en?rss=true Alzheimer Europe wrote to EU Vice-President for Democracy and Demography, Dubravka Šuica, and Health Commissioner, Stella Kyriakides, asking for dementia to be prioritised within EU policies, including the EU4Health programme. We have received a joint response from both offices. 29 Aug 2020 12:00:00 CEST 51c6a791c23223d486a5c989cc56fdff Other Articles <p style="text-align: justify;"><img align="left" src="http://alzheimereurope.newsweaver.com/v2files/shard1/56305/f8/86c55e5d956dcf46b2d983.jpg" style="margin: 5px;" width="150" height="102" hspace="5" vspace="5" alt="European Commission" /></p> <p style="text-align: justify;">Alzheimer Europe wrote to EU Vice-President for Democracy and Demography, Dubravka Šuica, and Health Commissioner, Stella Kyriakides, asking for dementia to be prioritised within EU policies, including the EU4Health programme. We have received a joint response from both offices.</p> https://www.alzheimer-europe.org/News/EU-developments/Tuesday-18-August-2020-Alzheimer-Europe-receives-response-from-Vice-President-and-Commissioner